New

Chrome Plugin Live! Redefine the way you read FinTwit šŸš€ Install Now

You have successfully sign out
Loading...
Shape
Iovance Biotherapeutics, Inc.
IOVA
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

3B

Biotechnology

Next Earning date - 05 Nov 2024

3B

Biotechnology

Next Earning date - 05 Nov 2024

10.17USD
Shape0.80Ā ( 8.54%)
favorite-chart

Relative Strenght

22
favorite-chart

Volume Buzz

26%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

45%

Quote Panel

Shape
Updated October 17, 2024
1W 4.41 % 1M 0.00 % 3M 22.38 % 1Y 204.49 %

Key Metrics

Shape
  • Market Cap

    3.09B


  • Shares Outstanding

    303.51M


  • Share in Float

    247.13M


  • Dividende

    0


  • Earning Date

    05 Nov 2024


  • Price Target

    10.17


  • Average Volume

    5.95M


  • Beta

    0.616


  • Range

    3.21-18.33


  • Industry

    Biotechnology


  • Website

    https://www.iovance.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

94.19x

P/S Ratio

3.77x

P/B Ratio

0.0

Debt/Equity

-1343.3%

Net Margin

$-1.6

EPS

How IOVA compares to sector?

P/E Ratio

Relative Strength

Shape

IOVA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$459M

Shape1376%

2025-Revenue

$0.77

Shape-128%

2025-EPS

$276M

Shape403%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Piper Sandler

downgrade

Previous: Overweight

2024-07-29

Now: Neutral

Goldman Sachs

downgrade

Previous: Buy

2022-12-08

Now: Neutral

Piper Sandler

initialise

Previous: Not converted

2022-10-31

Now: Overweight

Guggenheim

initialise

Previous: Not converted

2022-10-31

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.63
vsĀ -0.55

Q4.22

arrow
arrow

N/A

-0.62
vsĀ -0.63

Q1.23

arrow
arrow

N/A

-0.50
vsĀ -0.58

Q2.23

arrow
arrow

N/A

-0.47
vsĀ -0.63

Q3.23

arrow
arrow

N/A

-0.46
vsĀ -0.63

Q4.23

arrow
arrow

N/A

-0.45
vsĀ -0.62

Q1.24

arrow
arrow

N/A

-0.42
vsĀ -0.50

Q2.24

arrow
arrow

N/A

-0.34
vsĀ -0.47

Q3.24

arrow
arrow

N/A

-0.30
vsĀ -0.46

Q4.24

arrow
arrow

N/A

-0.27
vsĀ -0.45

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

NA

NAĀ  vsĀ NA

Q4.22

arrow
arrow

NA

NAĀ  vsĀ NA

Q1.23

arrow
arrow

NA

NAĀ  vsĀ NA

Q2.23

arrow
arrow

NA

238KĀ  vsĀ NA

Q3.23

arrow
arrow

NA

469KĀ  vsĀ NA

Q4.23

arrow
arrow

NA

482KĀ  vsĀ NA

Q1.24

arrow
arrow

NA

715KĀ  vsĀ NA

Q2.24

arrow
arrow

+12970%

31.1MĀ  vsĀ 238K

Q3.24

arrow
arrow

+11364%

53.8MĀ  vsĀ 469K

Q4.24

arrow
arrow

+15899%

77.1MĀ  vsĀ 482K

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-25%

-0.25
vsĀ -0.21

Q4.22

arrow
arrow

-20%

-0.20
vsĀ -0.25

Q1.23

arrow
arrow

-16%

-0.16
vsĀ -0.20

Q2.23

arrow
arrow

-18%

-0.18
vsĀ -0.16

Q3.23

arrow
arrow

-17%

-0.17
vsĀ -0.18

Q4.23

arrow
arrow

-20%

-0.20
vsĀ -0.17

Q1.24

arrow
arrow

-17%

-0.17
vsĀ -0.20

Q2.24

arrow
arrow

-13%

-0.13
vsĀ -0.17

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

246

246
vsĀ 250

-2%

Q4.22

arrow
arrow

226

226
vsĀ 246

-8%

Q1.23

arrow
arrow

237

237
vsĀ 226

5%

Q2.23

arrow
arrow

230

230
vsĀ 237

-3%

Q3.23

arrow
arrow

248

248
vsĀ 230

8%

Q4.23

arrow
arrow

251

251
vsĀ 248

1%

Q1.24

arrow
arrow

297

297
vsĀ 251

18%

Q2.24

arrow
arrow

305

305
vsĀ 297

3%

Earnings Growth

Latest News